Targeted Oncologyreports current advancements in cancer research, including interviews with oncology experts, conference coverage, clinical trial results, and the most recent approvals. Check out our weekly roundup below of the biggest news in oncology that we shared this week.

Follow the links below in our infographic to check out the full story.

This week, the FDA announced 2 new approvals for thetreatment of patients with multiple myelomaas well as fordetecting minimal residual diseasein patients with acute lymphoblastic leukemia or multiple myeloma. A roundup of all the FDA news from September 2018is also now available.

During aTargeted Oncologylive case-based peer perspectives presentation, Rachel Sanborn, MD, director of Thoracic Oncology, Providence Cancer Center, discussed treatment options for patients with nonsmall cell lung cancer(NSCLC).

In an interview, Javier A. Pinilla-Ibarz, MD, PhD, a senior member of Moffitt Cancer Center, discussed the current treatment landscape for chronic lymphocytic leukemia, as well as some ongoing research in the field.

The top video this week included Fabrice Barlesi, MD, head of the Multidisciplinary Oncology and Therapeutic Innovations Department at Aix-Marseille University and the Assistance Publique Hôpitaux de Marseille, France, where he discussed the importance of molecular testing in patients with NSCLC